Skip to main content

Table 1 Characteristics of the overall study population

From: Aspiration biopsy versus dilatation and curettage for endometrial hyperplasia prior to hysterectomy

Characteristics n (%)
Age, years 49.0 ± 6.5
BMIa, kg/m2 24.8 ± 4.6
Parity 1.8 ± 0.7
Menopause 40 (16.0)
Diabetes 9 (3.6)
Hypertension 35 (14.0)
Tamoxifen 21 (8.4)
Abnormal uterine bleeding 154 (61.6)
EM sampling method
 D&C 100 (40.0)
 Aspiration biopsy 150 (60.0)
Time interval between EM sampling & hysterectomy, months 1.6 ± 1.0
EM sampling pathology
 SH 76 (30.4)
 CH 42 (16.8)
 SAH 4 (1.6)
 CAH 128 (51.2)
Hysterectomy pathology
 Normal 35 (14.0)
 SH 68 (27.2)
 CH 24 (9.6)
 SAH 3 (1.2)
 CAH 64 (25.6)
 Carcinoma 56 (22.4)
  1. Data are mean ± SD or n (%) unless otherwise specifiedik
  2. aBMI data are missing for two patients
  3. BMI Body mass index; EM Endometrial; D&C Dilatation and curettage; SH Simple hyperplasia without atypia; CH Complex hyperplasia without atypia; SAH Simple atypical hyperplasia; CAH Complex atypical hyperplasia